- 209
- 35 522
HealthTree Foundation for Blood Cancers
United States
เข้าร่วมเมื่อ 27 เม.ย. 2022
HealthTree Foundation empowers patients with blood cancers at each step of their disease journey - from diagnosis, through education, care and on to a cure. The HealthTree Foundation does this through three areas of support; simplified patient education, support research driven by patient needs, and the use of data to solve patient and research problems.
A Faster Tandem CAR T-Cell Product, Zamto-Cel Being Studied in DLBCL | Nirav Shah, MD, MSHP | #ASH24
Dr. Nirav Shah from the Medical College of Wisconsin discusses the phase 2 study for zamtocabtagene autoleucel (zamto-cel), a CAR-T cell product for patients with relapsed/refractory diffuse large B-cell lymphoma.
Link to ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b
ASH Abstract: Interim Results from a Phase 2 Pivotal Study (DALY II USA) of Tandem CD20-CD19-Directed Non-Cryopreserved CAR-T Cells - Zamtocabtagene Autoleucel (Zamto-Cel) in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
#ASH24 #DLBCL #lymsm
Link to ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b
ASH Abstract: Interim Results from a Phase 2 Pivotal Study (DALY II USA) of Tandem CD20-CD19-Directed Non-Cryopreserved CAR-T Cells - Zamtocabtagene Autoleucel (Zamto-Cel) in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
#ASH24 #DLBCL #lymsm
มุมมอง: 2
วีดีโอ
Bispecific Antibody, AZD0486 Attacks a New Target in DLBCL | Sameh Gaballa, MD | #ASH24
3 ชั่วโมงที่ผ่านมา
Dr. Sameh Gaballa from Moffitt Cancer Center discusses an ongoing clinical trial for a new bispecific antibody, AZD0486, for patients with diffuse large B-cell lymphoma. Link to ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b ASH Abstract: Evaluation of AZD0486, a Novel CD19xCD3 T-Cell Engager, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in an Ongoing ...
Exploring Barriers to CAR T-Cell Therapy in Blood Cancer Patients | Yannis Valtis, MD | #ASH24
มุมมอง 13 ชั่วโมงที่ผ่านมา
Dr. Yannis Valtis from Memorial Sloan Kettering Cancer Center discusses a study revealing some of the common barriers that prevent patients from receiving CAR T-cell therapy. Link to ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b ASH Abstract: Barriers to Immune Effector Cell Therapy: Rapid Disease Progression, Concern for Toxicity, and Lack of Appropriate Tri...
Glofitamab for Relapsed/Refractory Large B-cell Lymphomas | Joshua Brody, MD | #ASH24
มุมมอง 33 ชั่วโมงที่ผ่านมา
Dr. Joshua Brody from the Icahn School of Medicine at Mount Sinai talks about the use of glofitamab for patients with large B-cell lymphoma. Link to ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b ASH Abstract: Fixed-Duration Glofitamab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed or Refractory Large B-Cell Lymphoma: 3-Year F...
Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70? | Muhammad Umair Mushtaq | #ASH24
มุมมอง 72 ชั่วโมงที่ผ่านมา
New Allogeneic Stem Cell Transplant research for Myelofibrosis unveiled by Dr. Muhammad Umair Mushtaq, MD ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b ASH Abstract: ashpublications.org/blood/article/144/Supplement 1/2172/532440/Outcomes-of-Allogeneic-Hematopoietic-Stem-Cell #ASH24 #Myelofibrosis #mpnsm Follow HealthTree: linktr.ee/HealthTreeUniversity
A Unique BTK Inhibitor, Pirtobrutinib for Patients with Pretreated CLL | Jeff Sharman, MD | #ASH24
มุมมอง 182 ชั่วโมงที่ผ่านมา
Dr. Jeff Sharman, Medical Director of Hematology Research at Sarah Cannon Research Institute, discusses the latest advancements in treating chronic lymphocytic leukemia (CLL) from the ASH 2024 conference. Key highlights include results from the Bruin CLL-321 study on pirtobrutinib, a non-covalent BTK inhibitor, and its potential to improve outcomes for patients with relapsed or refractory CLL. ...
Duvelisib + Venetoclax: A Time-Limited, All Oral Option for CLL | Jennifer Crombie, MD | #ASH24
มุมมอง 102 ชั่วโมงที่ผ่านมา
Dr. Jennifer Crombie from Dana-Farber Cancer Institute shares updated results from a phase 2 trial exploring the combination of duvelisib and venetoclax in relapsed or refractory chronic lymphocytic leukemia (CLL) and Richter syndrome. Link to ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b ASH Abstract: A Phase 2 Study of Duvelisib and Venetoclax in Patients w...
Promising Results for Odronextamab in Post CAR T Patients with DLBCL | Jennifer Crombie, MD | #ASH24
มุมมอง 92 ชั่วโมงที่ผ่านมา
Dr. Jennifer Crombie from Dana-Farber Cancer Institute shares exciting findings from the ELM-1 study, a phase 1 trial of the CD3xCD20 bispecific antibody, odronextamab, in relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Link to ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b ASH Abstract: Efficacy and Safety of Odronextamab Monotherapy in Patients...
Analyzing the Impact of Smoking on Myelodysplastic Syndromes | Sangeeth Venugopal, MD | #ASH24
มุมมอง 32 ชั่วโมงที่ผ่านมา
Dr. Sangeeth Venugopal shares findings from the National MDS History Study revealing how smoking affects the progression of myelodysplastic syndromes (MDS). She explains how smoking intensity influences MDS-specific genetic mutations, including ASXL1, SF3B1, and more, and its role in disease progression and survival outcomes. Discover why quitting smoking is critical for patients with MDS and i...
Adding Venetoclax to 7+3 Chemotherapy in Newly Diagnosed AML | Ioannis Mantzaris, MD | #ASH24
มุมมอง 262 ชั่วโมงที่ผ่านมา
Dr. Ioannis Mantzaris discusses adding venetoclax to 7 3 chemotherapy on newly diagnosed AML. Link to ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b ASH Abstract: Venetoclax Combined with "7 3" Induction Chemotherapy Induces High MRD-Negative Response Rates in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy across Ages #ASH24 #AML #leusm Follow Hea...
Addressing Socioeconomic Challenges in Acute Myeloid Leukemia Treatment | Mohamed Sorror, MD |#ASH24
มุมมอง 199 ชั่วโมงที่ผ่านมา
Dr. Mohamad Sorror from Fred Hutchinson Cancer Center shares findings from a pivotal study on acute myeloid leukemia (AML) that highlights how socioeconomic factors, such as education and poverty, impact access to life-saving treatments like bone marrow transplants. Dr. Sorror discusses how these barriers affect outcomes, the innovative strategies his team is developing to overcome them, and hi...
New Standard: Blinatumomab + Chemo in Childhood Acute Lymphoblastic Leukemia | Rachel Rau, MD|#ASH24
มุมมอง 2114 ชั่วโมงที่ผ่านมา
Dr. Rachel Rau from Seattle Children's Hospital discusses the groundbreaking results of a study using blinatumomab with chemotherapy for children with B-cell acute lymphoblastic leukemia that has since changed the way newly diagnosed pediatric patients are treated across the United States. Link to ASH playlist: healthtree.org/blood-cancer/university/modules/V33aLCfmYhGeYz3iLH8b ASH Abstract: Bl...
How HealthTree is Investing in Cures
มุมมอง 6316 ชั่วโมงที่ผ่านมา
Join Jenny Ahlstrom and experts in a webinar on curing myeloma, featuring insights, research updates, and ways to contribute. Q&A included! Recorded on December 11th, 2024 with Jenny Ahlstrom, Laura Gilman, Jeff Mulder and Taryn Placko. The HealthTree Foundation brings information from the experts to the patients! Learn more at healthtree.org/ Donate to the HealthTree Foundation or learn more a...
Improve Communication with Your Healthcare Team and Make Informed Decisions as a Lymphoma Patient
มุมมอง 12วันที่ผ่านมา
Join our webinar to enhance communication with your healthcare team, ask the right questions, and take an active role in your lymphoma care decisions Recorded on November 19th, 2024 as part of the Lymphoma Group in the Educational Webinar Program by HealthTree with Anni McKinnon, Ph.D. The HealthTree Foundation brings information from the experts to the patients! Learn more at healthtree.org/ D...
Bi-Monthly Blood Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions
มุมมอง 2214 วันที่ผ่านมา
Recorded on December 3rd, 2024 as part of the Financial Education Group in the Educational Webinar Program by HealthTree with Diahanna Vallentine. The HealthTree Foundation brings information from the experts to the patients! Learn more at healthtree.org/ Donate to the HealthTree Foundation or learn more about additional blood cancer support we offer here: give.healthtree.org/campaign/50-days-t...
What Chronic Lymphocytic Leukemia Patients Should Know about Richter Syndrome with Erin Parry, MD
มุมมอง 6714 วันที่ผ่านมา
What Chronic Lymphocytic Leukemia Patients Should Know about Richter Syndrome with Erin Parry, MD
New Research on Time-Limited Therapies for Chronic Lymphocytic Leukemia with Dr. Farrukh Awan, M.D.
มุมมอง 2121 วันที่ผ่านมา
New Research on Time-Limited Therapies for Chronic Lymphocytic Leukemia with Dr. Farrukh Awan, M.D.
Improving FDA Standards for AML Treatment: New Clinical Trials with Dr. Yazan Madanat, M.D.
มุมมอง 1621 วันที่ผ่านมา
Improving FDA Standards for AML Treatment: New Clinical Trials with Dr. Yazan Madanat, M.D.
New Research on CAR T-Cell Therapy Toxicities in Acute Lymphocytic Leukemia, Dr. Julio Thiebaud, M.D
มุมมอง 1521 วันที่ผ่านมา
New Research on CAR T-Cell Therapy Toxicities in Acute Lymphocytic Leukemia, Dr. Julio Thiebaud, M.D
New Clinical Trials for Diffuse Large B-Cell and T-Cell Lymphomas with Dr. Praveen Ramakrishnan, M.D
มุมมอง 721 วันที่ผ่านมา
New Clinical Trials for Diffuse Large B-Cell and T-Cell Lymphomas with Dr. Praveen Ramakrishnan, M.D
New Research on Biomarkers and Graft-Versus-Host Disease in MDS with Dr. Alejandro Minaros, M.D.
มุมมอง 721 วันที่ผ่านมา
New Research on Biomarkers and Graft-Versus-Host Disease in MDS with Dr. Alejandro Minaros, M.D.
Current Treatment Options and Things to Consider for Myelofibrosis Patients with Anand Patel, MD
มุมมอง 126หลายเดือนก่อน
Current Treatment Options and Things to Consider for Myelofibrosis Patients with Anand Patel, MD
Venetoclax: Everything You Need To Know
มุมมอง 84หลายเดือนก่อน
Venetoclax: Everything You Need To Know
Estate and Legacy Planning for Blood Cancer Patients: Protect Your Future and Leave a Lasting Impact
มุมมอง 74หลายเดือนก่อน
Estate and Legacy Planning for Blood Cancer Patients: Protect Your Future and Leave a Lasting Impact
To Treat or Not To Treat? A Discussion about Early Intervention for Myelofibrosis with Dr. Yacoub.
มุมมอง 104หลายเดือนก่อน
To Treat or Not To Treat? A Discussion about Early Intervention for Myelofibrosis with Dr. Yacoub.
CAR-T Therapy and Stem cell transplant in Lymphoma patients: Current treatment landscape
มุมมอง 49หลายเดือนก่อน
CAR-T Therapy and Stem cell transplant in Lymphoma patients: Current treatment landscape
Things to Think About When Choosing a Chronic Lymphocytic Leukemia treatment with Joanna Rhodes, MD
มุมมอง 105หลายเดือนก่อน
Things to Think About When Choosing a Chronic Lymphocytic Leukemia treatment with Joanna Rhodes, MD
Caring for the Caregiver: Effective Stress Management Strategies
มุมมอง 40หลายเดือนก่อน
Caring for the Caregiver: Effective Stress Management Strategies
How does diet impact Myeloproliferative Neoplasms? with Angela Fleischman, MD
มุมมอง 992 หลายเดือนก่อน
How does diet impact Myeloproliferative Neoplasms? with Angela Fleischman, MD
Plz any cure for colon cancer to many children dying from thet plz help them the are children
Sir pls do somthing and help the peopel i thing FDA has the cancer cure plz help children
Thank you so much for posting this Dr. Joanna Rhodes . It gives so much relevant information
Hi, hope u r doing good. I was diagnosed with cancer{(aml [inv16(16:16)} and doctor advised for bmt, so i did(haplo). Now, biopsy report is normal but mrd is positive with 227 aml copies. What should i do now?
Clearest insight I have found thank you
We're so glad you found this recording helpful. We have a variety of additional follicular lymphoma resources you can access by visiting our website: www.healthtree.org/follicular-lymphoma/community
Very nice!
Thanks for the forecast! Could you help me with something unrelated: I have a SafePal wallet with USDT, and I have the seed phrase. (behave today finger ski upon boy assault summer exhaust beauty stereo over). What's the best way to send them to Binance?
you go then!
Sir, what to do for hypo plastic MDS del 20q?
😊
Wise ... live each day as if it is your first ... and never give up hope!
Thank you for this advice Dr Chavez.
Hi Doctor, do you treat autoimmune hemolytic Anemia?
That is very promising,if the drug is 10 times stronger than venetoclax maybe that combination will offer a cure to some patients.
Absolutely terrific presentation by Dr Thompson! As a CLL-Small Cell B, I have just started Rx with Brukinsa for very bulky Axillary nodes. On the lookout for potential infections!
What will be the best therapy for MDS del 20q?.please suggest me
My momma was saved by this very treatment! Thank you Dr.Strati and your team! We are forever grateful.
This is amazing. We're so glad to hear a little bit about your mom's story!
*Promo sm*
Hope is allways available... God bless your efforts...
My dad is 67, turns 68 Feb 5th. He has non-small cell lung cancer and AML. He decided to do no treatment, and he has been told he has less than 6 months. He's refusing hospice, and as his daughter that lives in the home with him, all the responsibility is put on me. He also doesn't want to believe his pain is from the cancer. He believes he might not die or is hopeful he won't. This has been very hard to deal with. Any advice would be helpful.
Thank you for watching! I'm sorry to hear about your father's diagnosis. Being a caregiver in this situation is a big responsibility and can feel very overwhelming. We have several articles/events on caregiving that might be helpful. Reach out to me at mary@healthtree.org and I can share those resources with you!
@@HealthTreeforbloodcancers Thank you I will.
Exciting.
So amazing!!!!!
Well done, Dr. Mannis. Thanks.
We are glad you enjoyed this presentation!
Thank you for making the video
found out I have AML FTL3 in july and I go for a BMT after thanksgiving. I am scared to death